What therapeutic agents can genetically modified plants produce?

• A. Amino acids and vitamins
• B. Enzymes for digestion
• C. Painkillers, vaccines, synthetic rubber, and melanin
• D. Antibiotic compounds only

Answer: (C)

Genetically modified plants have the ability to be engineered to produce a wide array of therapeutic agents, making them a significant tool in biotechnology. By utilizing genetic engineering techniques, scientists can introduce specific genes into plants, allowing them to synthesize complex molecules that can have therapeutic purposes.

Among the many possibilities, plants can be modified to produce painkillers, which are essential in managing pain in various medical conditions. Additionally, plants can be engineered to produce vaccines, which serve as a preventive measure against infectious diseases by stimulating the immune response. Synthetic rubber, while primarily associated with industrial applications, can also be derived from genetically modified plants to enhance certain therapeutic applications. Lastly, melanin, a pigment that can be important in protecting against UV radiation and has potential therapeutic functions, can also be produced by these engineered plants.

The versatility of genetically modified plants highlights their potential in producing complex biologics that traditional pharmaceutical manufacturing processes may struggle to create efficiently or at a lower cost. This aspect of biotechnology not only expands the range of available therapeutic agents but also fosters innovations in agricultural practices where these plants can also contribute to food security and health improvement simultaneously.